Daily non-political popular news in brief.
New study looks at long-term drug costs for treating AIDS in Brazil
11-12-2007 · EurekAlert!AIDS continues to be a staggering global public health problem. However, little is known about the long-term costs associated with providing drugs to AIDS patients in developing countries. To study those long-term cost trends, researchers from the Harvard School of Public Health have performed the first detailed analysis of AIDS drug cost trends in Brazil.
Read more »
Keywords: study, looks, long-term, drug, costs, treating, aids, brazil, look, long, term, cost, aid
« Previous | Next »
Similar news on "New study looks at long-term drug costs for treating AIDS in Brazil":
- Split the difference: Pill-splitting study looks at cost-saving step that could be used by millions
06-11-2007 · EurekAlert!
Slicing certain pills in half could slice a hefty amount off of Americas prescription drug costs. While only some types of pills can be split safely, they include popular cholesterol-lowering drugs. Now, the first prospective randomized controlled trial of pill-splitting gives more evidence of how the practice could be used.
Similar news · Read more »
- Drug therapy can reduce preterm births and decrease lifetime medical costs
04-26-2007 · EurekAlert!
Researchers from MetroHealth Medical Center and Case Western Reserve University in Cleveland, OH found that treating expectant mothers who have had previous spontaneous preterm births with 17 Alpha Hydroxyprogesterone caproate (17P) and reducing the incidence of another preterm birth would consequently reduce both short-term and lifetime medical costs in offspring by $2 billion per year. The results of their study are reported in the March issue of the American Journal of Obstetrics & Gynecology.
Similar news · Read more »
- Long-term financial costs associated with prostate cancer treatment
12-21-2006 · EurekAlert!
A new study reveals that the cumulative cost of prostate cancer is, on average, $42,570 over five years. Watchful waiting was the least expensive treatment while radiation and androgen deprivation therapy were the most expensive.
Similar news · Read more »
- Study finds major variation in Medicare Rx drug costs
01-10-2007 · EurekAlert!
As Congress debates changes to the Medicare Part D prescription drug plans, a new study finds tremendous variation in what seniors in different states pay for the same medications, even if they choose the lowest-cost Part D plans in their areas. The highest costs often occur in the lowest-income, lowest cost-of-living areas.
Similar news · Read more »
- Cost control measures limit patient and physician choice in psychotropic medications
03-01-2007 · EurekAlert!
A new Brandeis University study published online in Clinical Therapeutics suggests that private health plans increasingly rely on escalating copayments to manage drug costs, as opposed to administrative controls. This makes treatment more expensive in many cases for patients, and may affect adherence to treatment, said lead author Dominic Hodgkin, associate professor at the Schneider Institute for Behavioral Health, Heller School for Social Policy and Management at Brandeis University.
Similar news · Read more »
- Antibody reduces incidence of acute rejection in high-risk kidney transplant patients
11-08-2006 · EurekAlert!
Nearly 70 percent of kidney transplant patients get short-term drug therapy initially administered during surgery to help prevent rejection. In the first direct comparison of the two drugs most commonly given to ward off acute kidney rejection, an international study led by Washington University School of Medicine in St. Louis shows that one -- anti-thymocyte globulin -- is superior. The results also suggest the drug could potentially save millions of dollars in health care costs.
Similar news · Read more »
- Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
06-26-2007 · EurekAlert!
New research carried out by researchers in Nepal has shown that a new and affordable drug, Gatifloxacin, may be more effective at treating typhoid fever than the drug currently recommended by the World Health Organization. The study, funded by the Wellcome Trust, has implications for the treatment of typhoid particularly in areas where drug resistance is a major problem.
Similar news · Read more »
- Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
06-27-2007 · EurekAlert!
New research carried out by researchers in Nepal has shown that a new and affordable drug, gatifloxacin, may be more effective at treating typhoid fever than the drug currently recommended by the World Health Organization. The study, funded by the Wellcome Trust, has implications for the treatment of typhoid particularly in areas where drug resistance is a major problem. The results are published in the June 27 issue of the online, open-access journal PLoS ONE.
Similar news · Read more »
- Study to look at aspirin as aid to conception, healthy pregnancy
02-22-2007 · EurekAlert!
Researchers at the University at Buffalo and the University of Utah are beginning a clinical trial to test whether aspirin can improve a woman's chances of becoming pregnant and of maintaining a pregnancy to term.
Similar news · Read more »
- Cost-benefit analysis: Combo treatment costs more, saves money later
11-07-2006 · EurekAlert!
From a health insurer's perspective, the most effective cancer treatment may also be the most cost-effective, according to a new study sponsored by the Radiation Therapy Oncology Group (RTOG 91-11). Compared to higher-priced combination treatments, the least expensive, single-modality cancer treatment may cost more in the long run because of the costs associated with treating complications and recurrence of cancer.
Similar news · Read more »
